Home › Funds › Alta Partners Management Company, L.P. › VIR
Alta Partners Management Company, L.P. position in VIR
VIR BIOTECHNOLOGY INC · Health Care
Alta Partners Management Company, L.P. reported holding 509,917 shares of VIR (VIR BIOTECHNOLOGY INC) in its Q2 2026 13F filing — a position valued at US$5.2M, representing 4.08% of its reported portfolio and ranking #2 among its reported holdings. Alta Partners Management Company, L.P. has disclosed VIR holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Alta Partners Management Company, L.P.'s VIR position evolved
Alta Partners Management Company, L.P. first disclosed a stake in VIR in Q4 2024 at 489,485 shares (US$3.6M). The position peaked in Q2 2026 at 509,917 shares, worth US$5.2M. Across 7 filings, Alta Partners Management Company, L.P. increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 509,917 shares valued at US$5.2M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 489.49K | $3.59M | New |
| Q1 2025 | 501.92K | $3.25M | Add |
| Q2 2025 | 509.92K | $2.57M | Add |
| Q3 2025 | 509.92K | $2.91M | Hold |
| Q4 2025 | 509.92K | $3.07M | Hold |
| Q1 2026 | 509.92K | $4.57M | Hold |
| Q2 2026 | 509.92K | $5.20M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VIR and 13F data
VIR (VIR BIOTECHNOLOGY INC) is a Health Care company. 49 other funds we track also report a position in VIR — the largest reported positions include ARCH Venture Management, LLC (US$129.4M), SB INVESTMENT ADVISERS (UK) LTD (US$111.6M), GSK plc (US$87.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VIR
- ARCH Venture Management, LLC 12.69M sh · $129.35M · Q2 2026
- SB INVESTMENT ADVISERS (UK) LTD 10.95M sh · $111.56M · Q2 2026
- GSK plc 8.55M sh · $87.13M · Q2 2026
- ADAR1 Capital Management, LLC 2.46M sh · $25.03M · Q2 2026
- Boxer Capital Management, LLC 1.87M sh · $19.01M · Q2 2026
- GordonMD Global Investments LP 1.35M sh · $13.79M · Q2 2026
- Sio Capital Management, LLC 1.08M sh · $10.96M · Q2 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 853.68K sh · $8.70M · Q2 2026
- Saturn V Capital Management LP 770.64K sh · $7.85M · Q2 2026
- Jones Hill Capital LP 659.21K sh · $6.72M · Q2 2026
- Avidity Partners Management LP 519.30K sh · $5.29M · Q2 2026
More on Alta Partners Management Company, L.P.
FAQ
How long has Alta Partners Management Company, L.P. held VIR?
Alta Partners Management Company, L.P. has disclosed VIR holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is Alta Partners Management Company, L.P.'s current position in VIR?
As of Q2 2026, Alta Partners Management Company, L.P. holds 509.92K shares of VIR (VIR BIOTECHNOLOGY INC), valued at $5.20M, representing 4.08% of its reported portfolio and ranking #2.
Has Alta Partners Management Company, L.P. been buying or selling VIR?
In the latest 13F filing (Q2 2026), Alta Partners Management Company, L.P. held unchanged its position in VIR. The position peaked in Q2 2026 at 509.92K shares.
Which other funds hold VIR?
Other major institutional holders of VIR include ARCH Venture Management, LLC, SB INVESTMENT ADVISERS (UK) LTD, GSK plc, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.